title: Anemia and reversible reticulocytopenia associated with extended quinupristin/dalfopristin.
authors.forename: Pamela C
authors.initials: PC
authors.lastname: Evans
authors.forename: James P
authors.initials: JP
authors.lastname: Almas
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Criddle
mesh_terms: D000328:Adult; D000740:Anemia / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006621:Hip Joint / Q000382:microbiology; D006801:Humans; D008297:Male; D012156:Reticulocytes / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus; D014769:Virginiamycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C062940:quinupristin-dalfopristin